ArticleOncotarget2017

Enhancing synthetic lethality of PARP-inhibitor and cisplatin in BRCA-proficient tumour cells with hyperthermia.

Arlene L Oei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.